Supplementary Table 1 from Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer

crossref(2023)

引用 0|浏览4
暂无评分
摘要

Supplementary Table 1: Adverse Events Amongst All Patients Treated on Trial (n=22)

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要